At New Approach, we use a technology capable of virtual screening to identify the most promising drugs for specific therapeutic or biological targets. This approach reduces the drug development process by 25%. At the moment, New Approach has generated promising nutraceutical and drug-repurposing candidates for chronic myeloid leukemia, SARS-CoV-2, depression, migraine, obesity, hyperglycemia, hypercholesterolemia, and erectile dysfunction. We also have a partnership with a Portuguese university conducting in vitro testing for four therapeutic targets.
Representatives
CEO
New Approach - Machine Learninf for Pharma&Nutraceuticals
We are an SME that uses a validated machine learning method to identify the most promising drugs and nutraceuticals for a specific target.
Partner seeks Consortium/Coordinator
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-06: Support to European Research Area (ERA) action on accelerating New Approach Methodologies (NAMs) to advance biomedical research and testing of medicinal products and medical devices
Author
CEO at New Approach - Machine Learninf for Pharma&Nutraceuticals